This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.This project integrates spatial analytic techniques and traditional case-control methods in epidemiology to study environmental risk factors for lung cancer in New Hampshire. We will adopt a three-phase approach. First, a geographic information system (GIS), which is the technical environment in which spatial analyses are performed, will be used to reveal spatial patterns and relationships between environmental factors (such as fine particulate air pollution) and lung cancer in New Hampshire. Second, traditional population-based, case-control methods of epidemiology will be used to study individual-level risk factor information (collected from questionnaires, drinking water samples, toenails clippings, sera, and germ-line DNA). This will permit us to model causal relations between environmental factors and risk of incident lung cancer in New Hampshire. As part of this approach, we will explore potential modifications in relative risk due to synergy between exposures (arsenic and smoking), host genetic susceptibility, dietary factors, and gender. We also will employ multilevel modeling (hierarchical regression) of individual lung cancer risk using group-level (ecologic-geographic) exposure information (e.g., fine particulate air pollution) and individual-level exposure information (e.g., smoking status, age, gender, education, occupation, use of wood burning stoves, water arsenic concentration, toenail arsenic concentration, DNA repair genotype, and other variables). Multilevel modeling will allow us to improve estimates of individual lung cancer risk by including group-level data that have no individual-level analogue (e.g., exposure to fine particulate air pollution). Third, using spatial environmental data and risk models built in phase 2, we will create a risk map of lung cancer in New Hampshire. We will test the validity of our environmental models and our risk map of lung cancer using newly collected lung cancer incidence data from New Hampshire. Through this three-phase approach, we expect that new etiologic factors for lung cancer will be uncovered and that this information will aid scientists and policy makers regarding risk assessment and disease prevention. This project will also set the stage for a comprehensive regional environmental health information system that will serve as a database and knowledgebase for future environmental health studies of lung diseases and other health outcomes in New Hampshire.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR018787-06
Application #
7720660
Study Section
Special Emphasis Panel (ZRR1-RI-6 (01))
Project Start
2008-08-11
Project End
2009-04-30
Budget Start
2008-08-11
Budget End
2009-04-30
Support Year
6
Fiscal Year
2008
Total Cost
$359,825
Indirect Cost
Name
Dartmouth College
Department
Physiology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Demidenko, Eugene; Glaholt, S P; Kyker-Snowman, E et al. (2017) Single toxin dose-response models revisited. Toxicol Appl Pharmacol 314:12-23
Ben Khedher, Soumaya; Neri, Monica; Papadopoulos, Alexandra et al. (2017) Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium. Int J Cancer 141:309-323
Fehringer, Gordon; Brenner, Darren R; Zhang, Zuo-Feng et al. (2017) Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. Int J Cancer 140:1976-1984
Madan, Juliette C (2016) Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health. Clin Ther 38:740-6
Chen, Li-Shiun; Baker, Timothy; Hung, Rayjean J et al. (2016) Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine 11:219-226
Hammond, John H; Hebert, Wesley P; Naimie, Amanda et al. (2016) Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers. mSphere 1:
Chen, Li-Shiun; Hung, Rayjean J; Baker, Timothy et al. (2015) CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst 107:
Andrew, Angeline S; Marsit, Carmen J; Schned, Alan R et al. (2015) Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence. Int J Cancer 137:1158-66

Showing the most recent 10 out of 133 publications